CollPlant Inaugurates its Industrial Greenhouse for the Scale up of Unique, Proprietary Transgenic Tobacco Plant and Production System for Type I Human Collagen

CollPlant, Innovation in BioMaterials, Kiryat Shmona, Israel, October 8th, 2007, a biotechnology company specializing in the development and commercialization of safe, plant-derived human collagen and protein-based biomaterials for the healthcare industry, recently inaugurated its state-of-the-art greenhouse representing a step increase in collagen biomaterials supply. The breakthrough scientific achievements of CollPlant coupled with the establishment of a 1000sqm greenhouse which houses thousands of the Company’s human collagen producing transgenic tobacco plants, bring the Company closer to realizing its declared intention: to supply industry with large scale quantities of safe human recombinant collagen globally.